SENP5 and hepatocellular carcinoma: Saikosaponin-d has been shown to reduce the malignance, in particular, Sonic Hedgehod-mediated EMT, of HCC cells, while boosting their sensitivity to other drug systems under hypoxia, through specific activation of SENP5, which is associated with GLI1 desumoylation [126].